Test-retest reliability and minimal detectable change of Dutch-Flemish Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests for musculoskeletal disorders

荷兰-佛兰德斯患者报告结局测量信息系统 (PROMIS®) 计算机化自适应测试在肌肉骨骼疾病中的重测信度和最小可检测变化

阅读:2

Abstract

OBJECTIVE: To examine the test-retest reliability and minimal detectable change (MDC) of the Dutch-Flemish Patient Reported Outcomes Measurement Information System (DF-PROMIS) Pain Interference (PI) v1.1, Physical Function (PF) v1.2, and Upper Extremity (UE) v2.0 computerized adaptive tests (CATs) in patients with musculoskeletal conditions receiving physical therapy in primary care. DESIGN: Observational cohort study. METHODS: Patients with musculoskeletal conditions of the spine or upper extremity were recruited from fourteen physical therapy practices. Participants completed DF-PROMIS CATs at baseline and again three to fourteen days later. Test-retest reliability was evaluated using the intraclass correlation coefficient (ICC) (two-way random effects, absolute agreement) and minimal detectable change (MDC). Reliability at the participant-level was visually represented by plotting test-retest scores with corresponding 95% confidence intervals (CIs). RESULTS: Data from 225 patients were analyzed. The DF-PROMIS CATs demonstrated sufficient test-retest reliability, with ICC values ranging from 0.79 to 0.91. MDC values ranged from 4.80 to 6.08 across all measurements. Participant-level reliability was high (0.9-0.95) for most measurements but lower for scores further from the mean. The 95% CIs for test-retest measurements overlapped in 95.3% of measurement pairs. CONCLUSION: The DF-PROMIS PF, UE, and PI domain CATs demonstrated sufficient reliability and precision in patients with musculoskeletal conditions receiving physical therapy in primary care practices. Future research should focus on implementing DF-PROMIS CATs in clinical practice, examining their responsiveness, and evaluating their feasibility. Adoption of DF-PROMIS domains as outcomes in intervention studies and clinical practice will enhance interpretability and comparability of results across different patient groups.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。